Sign up for a free trial and join thousands of other leading professionals. Click here to start!

Cell Therapeutics Inc. News

This is an old version of this news section. Please find the new version yourself or contact us.

TAKE THIS POLL
Regardless of your general preferences, which U.S. presidential candidate's Iraq policy do you support? (Jul. 15, 2008) John McCain's policy. Barack Obama's 's policy. Don't know.

Biogen Idec's second-quarter profit rises 11 per cent to $206.6M 25 Jul 2008 23:34 GMT
... recorded $59 million in sales of the cancer drug Zevalin, which it sold to Cell Therapeutics last year but for which it still receives sales of the psoriasis drug Fumaderm ...
Analyst lowers Boeing rating 25 Jul 2008 07:36 GMT
... Boeing's defense programs may be cut next year and concerns over upcoming labor negotiations. Cell Therapeutics said it will sell $22.25 million in new convertible notes bearing 18.33 percent interest ...
Cell Therapeutics, Inc. Announces Single Institutional Investor to Purchase $44.5 Million of Units Consisting of Senior 24 Jul 2008 06:29 GMT
... Cell Therapeutics, Inc. Announces Single Institutional Investor to Purchase $44.5 Million of Units Consisting of Senior ...
Cell Therapeutics, Inc. Announces Single Institutional Investor to Purchase $44.5 Million of Units C 24 Jul 2008 06:02 GMT
... Cell Therapeutics, Inc. Announces Single Institutional Investor to Purchase $44.5 Million of Units Consisting of Senior ...
Cell Therapeutics, Inc. Announces Single Institutional Investor to Purchase $44.5 Million of Units Consisting of Senior Convertible Notes and Warrants 24 Jul 2008 06:01 GMT
... Increase Original Warrant Amount by an Additional $44.5 million SEATTLE, July 24 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (Nasdaq and MTA: CTIC) today announced that a single institutional investor has agreed ...